Sedative and mechanical hypoalgesic effects of butorphanol in xylazine-premedicated donkeys.
Authors: Lizarraga I, Castillo-Alcala F
Journal: Equine veterinary journal
Summary
# Editorial Summary: Butorphanol and Xylazine Combinations in Donkey Sedation Whilst α2-adrenoceptor agonists and opioids are routinely combined in equine practice, their specific effects in donkeys remain poorly characterised. Lizarraga and Castillo-Alcala investigated how adding butorphanol at escalating doses (10–40 µg/kg) to xylazine (0.5 mg/kg) influenced sedation depth and pain threshold in six donkeys using a blinded, randomised crossover design, with sedation scores, head carriage and mechanical nociceptive thresholds measured over 120 minutes. Xylazine alone produced sedation and pain relief, but butorphanol augmented both effects dose-dependently, with the 40 µg/kg combination delivering significantly greater pain threshold elevation in the critical 30–60 minute window compared to xylazine monotherapy. For farriers, veterinarians and equine practitioners managing donkeys requiring procedural restraint, this finding suggests that butorphanol at 40 µg/kg offers a practical pharmacological strategy to enhance both sedation quality and analgesia—potentially permitting safer standing procedures where deeper restraint is needed without resorting to general anaesthesia.
Read the full abstract on PubMed
Practical Takeaways
- •When chemically restraining donkeys for procedures, adding butorphanol (particularly 40 µg/kg) to xylazine provides better sedation and pain relief than xylazine alone
- •This xylazine-butorphanol combination appears safe and effective for donkey restraint, though the study was limited to 6 animals and further confirmation would strengthen recommendations
- •Consider this combination for donkeys undergoing procedures where sedation and analgesia are both needed, as it offers practical advantages over single-agent sedation
Key Findings
- •All xylazine-butorphanol combinations induced sedation in donkeys, with butorphanol enhancing sedation scores at 0-30 minutes across all doses compared to saline control
- •Mechanical hypoalgesia was significantly improved by xylazine-butorphanol combinations, with 30-40 µg/kg butorphanol doses showing sustained hypoalgesic effects at 30-60 minutes
- •Xylazine at 0.5 mg/kg with butorphanol 40 µg/kg produced the most robust sedation and mechanical hypoalgesia suitable for clinical procedures in donkeys